OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION
Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 1
Abstract
Omalizumab is a monoclonal antibody against immunoglobulin E (IgE) which prevents free IgE from interacting with the high and low affinity IgE receptors on effector cells. Results of various studies proved that omalizumab improves asthma control, reduces exacerbations, corticosteroids use and have the potential to reduce airway remodeling. Moreover, effectiveness of omalizumab is similar in high and low eosinophil subgroups. The clinical efficacy and safety of omalizumab are documented in many clinical trials.
Authors and Affiliations
Deimantė Hoppenot
Keywords
Related Articles
- EP ID EP502470
- DOI -
- Views 112
- Downloads 0
FLUTICASONE FUROATE/VILANTEROL 92/22 ΜG ONCEADAY VS BECLOMETHASONE DIPROPIONATE/FORMOTEROL 100/6 ΜG B.I.D. IN ASTHMA PATIENTS: A 12WEEK PILOT STUDY
A 12-week pilot study was conducted to compare once-daily Fluticasone/Vilanterol 92/22 μg combination with twice daily Beclomethasone/Formoterol 100/6 μg association in moderate asthma, in terms of quality o...
EOSINOPHILS VIABILITY INCREASES AFTER THEIR INTERACTION WITH AIRWAY SMOOTH MUSCLE CELLS IN ASTHMA
Background. Viability of peripheral blood eosinophils are significantly lower than airway eosinophils. It may be assumed that direct contact between eosinophils and pulmonary structural cells increase eosinophils surviva...
DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct form of pulmonary hypertension due to chronic obstruction of the pulmonary artery tree. If left untreated, the prognosis is poor. Pulmonary endarterect...
HIGHLIGHTS FOR INSOMNIA DIAGNOSTICS AND TREATMENT
Insomnia is one of the most common sleep disorders, characterised by repeated disability to fall asleep or continue to sleep, and worsened sleep quality, that affects daytime functioning and does not reveal in spite of a...
NAUJAI DIAGNOZUOTŲ LĖTINĖS OBSTRUKCINĖS PLAUČIŲ LIGOS ATVEJŲ TIESIOGINIAI MEDICININIAI KAŠTAI LIETUVOJE
Background. Chronic obstructive pulmonary disease (COPD) is an under-diagnosed, life-threatening lung disease, which is mainly caused by active smoking, and provokes significant financial burden for the health care secto...